Sensient Technologies (NYSE:SXT – Get Free Report) had its target price reduced by UBS Group from $157.00 to $154.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock. UBS Group‘s price target would suggest a potential upside of 30.43% from the stock’s previous close.
Several other research firms have also recently weighed in on SXT. Wall Street Zen cut shares of Sensient Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings lowered shares of Sensient Technologies from a “buy (b+)” rating to a “buy (b)” rating in a research report on Friday, October 23rd. Robert W. Baird increased their target price on Sensient Technologies from $125.00 to $140.00 and gave the company an “outperform” rating in a research note on Monday, July 27th. Rothschild & Co Redburn initiated coverage on Sensient Technologies in a research note on Wednesday, July 8th. They issued a “neutral” rating and a $125.00 target price on the stock. Finally, Zacks Research downgraded Sensient Technologies from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 25th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Sensient Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $139.67.
Check Out Our Latest Analysis on Sensient Technologies
Sensient Technologies Price Performance
Sensient Technologies stock traded up $0.44 during midday trading on Monday, hitting $118.07. 1,843,775 shares of the company’s stock were exchanged, compared to its average volume of 405,762. The company has a market cap of $5.03 billion, a P/E ratio of 29.74 and a beta of 0.86. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.52 and a current ratio of 3.97. The stock has a 50-day moving average price of $131.59 and a two-hundred day moving average price of $113.61. Sensient Technologies has a 52-week low of $82.60 and a 52-week high of $138.82.
Sensient Technologies (NYSE:SXT – Get Free Report) last issued its quarterly earnings results on Friday, October 30th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.04. The firm had revenue of $455.84 million during the quarter, compared to the consensus estimate of $459.05 million. Sensient Technologies had a return on equity of 14.08% and a net margin of 9.69%. The company’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter last year, the company posted $0.96 EPS. On average, equities research analysts forecast that Sensient Technologies will post 4.20 earnings per share for the current year.
Insider Buying and Selling at Sensient Technologies
In other news, Director Mario Ferruzzi sold 1,200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $129.48, for a total value of $155,376.00. Following the transaction, the director owned 7,352 shares in the company, valued at approximately $951,936.96. This trade represents a 14.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.
Institutional Investors Weigh In On Sensient Technologies
Several institutional investors have recently added to or reduced their stakes in the company. Vise Technologies Inc. increased its position in shares of Sensient Technologies by 8.2% in the third quarter. Vise Technologies Inc. now owns 2,387 shares of the specialty chemicals company’s stock valued at $312,000 after acquiring an additional 180 shares during the period. Schwartz Investment Counsel Inc. purchased a new stake in shares of Sensient Technologies during the third quarter worth about $217,000. Oppenheimer & Co. Inc. purchased a new stake in shares of Sensient Technologies during the third quarter worth about $1,229,000. Tower View Wealth Management LLC grew its stake in shares of Sensient Technologies by 0.9% in the third quarter. Tower View Wealth Management LLC now owns 17,902 shares of the specialty chemicals company’s stock worth $2,340,000 after purchasing an additional 158 shares during the last quarter. Finally, Gibbs Wealth Management grew its stake in shares of Sensient Technologies by 6.4% in the third quarter. Gibbs Wealth Management now owns 9,817 shares of the specialty chemicals company’s stock worth $1,283,000 after purchasing an additional 591 shares during the last quarter. Hedge funds and other institutional investors own 90.86% of the company’s stock.
About Sensient Technologies
Sensient Technologies Corporation is a global manufacturer of colors, flavors and extracts used in food, beverages, pharmaceuticals, cosmetics and other consumer and industrial products. The company develops customized ingredient solutions designed to improve the appearance, taste, aroma and overall sensory qualities of finished products.
Sensient’s product portfolio includes natural and synthetic food colors, coloring systems, flavor compounds, botanical extracts and other specialty ingredients.
Further Reading
- Five stocks we like better than Sensient Technologies
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Sensient Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensient Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
